Trial intelligence / Profile preview

Effect of tourniquet use on cefuroxime tissue penetration in orthopedic surgery

2018-000217-21Phase 4Completed

Sponsor
Aarhus University Hospital
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of cefuroxime in None (2 arms), sponsored by Aarhus University Hospital. Primary endpoints: Time above MIC in tissues, Tissue penetration ratios and 1 more. Started Feb 2018; status: completed.

02

Drugs

cefuroxime

Beyond the preview

Go deeper on 2018-000217-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-000217-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call